Literature DB >> 11698434

Inefficient ZAP-70 phosphorylation and decreased thymic selection in vivo result from inhibition of NF-kappaB/Rel.

A L Mora1, S Stanley, W Armistead, A C Chan, M Boothby.   

Abstract

Signaling from the TCR regulates T lymphoid survival, deletion by apoptosis, and selective clonal expansion. One set of signaling pathways activated during thymic selection leads to degradation of a cytosolic retention protein, the inhibitor of kappaB (IkappaB)alpha, followed by nuclear translocation of the NF-kappaB/Rel family of transcription factors. It has been found previously that NF-kappaB proteins mediate a pathway signaling the survival of mature T cells and protection of thymocytes against TNF-induced apoptosis. In contrast, we show in this study that a transgenic inhibitor of NF-kappaB/Rel signaling interferes with the negative selection of immature thymocytes by endogenous MHC ligands in vivo. Positive selection of the H-Y TCR also was diminished. This attenuation of thymic selection efficiency was associated with decreased ZAP-70 phosphorylation and TCR signaling of CD69 induction. These findings demonstrate that the NF-kappaB transcriptional pathway plays an important role in normal processes of clonal deletion and they indicate that the NF-kappaB/IkappaB axis can regulate the efficiency of TCR signaling.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11698434     DOI: 10.4049/jimmunol.167.10.5628

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Tenuous paths in unexplored territory: From T cell receptor signaling to effector gene expression during thymocyte selection.

Authors:  Lie Wang; Yumei Xiong; Rémy Bosselut
Journal:  Semin Immunol       Date:  2010-10       Impact factor: 11.130

2.  IkappaBalpha/IkappaBepsilon deficiency reveals that a critical NF-kappaB dosage is required for lymphocyte survival.

Authors:  Bertrand Goudeau; François Huetz; Sandrine Samson; James P Di Santo; Ana Cumano; Amer Beg; Alain Israël; Sylvie Mémet
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-09       Impact factor: 11.205

Review 3.  Roles of the NF-kappaB pathway in lymphocyte development and function.

Authors:  Steve Gerondakis; Ulrich Siebenlist
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-23       Impact factor: 10.005

Review 4.  The complicated role of NF-kappaB in T-cell selection.

Authors:  Mingzhao Zhu; Yangxin Fu
Journal:  Cell Mol Immunol       Date:  2010-03       Impact factor: 11.530

Review 5.  NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms.

Authors:  Li Yu; Ling Li; L Jeffrey Medeiros; Ken H Young
Journal:  Blood Rev       Date:  2016-10-13       Impact factor: 8.250

6.  Significant involvement of nuclear factor-κB-inducing kinase in proper differentiation of αβ and γδ T cells.

Authors:  Koji Eshima; Motohito Okabe; Satoshi Kajiura; Haruka Noma; Nobukata Shinohara; Kazuya Iwabuchi
Journal:  Immunology       Date:  2014-02       Impact factor: 7.397

Review 7.  NF-κB pathways in hematological malignancies.

Authors:  Chiara Gasparini; Claudio Celeghini; Lorenzo Monasta; Giorgio Zauli
Journal:  Cell Mol Life Sci       Date:  2014-01-14       Impact factor: 9.261

8.  Differential role of the transcription factor NF-kappaB in selection and survival of CD4+ and CD8+ thymocytes.

Authors:  Eijiro Jimi; Ian Strickland; Reinhard E Voll; Meixiao Long; Sankar Ghosh
Journal:  Immunity       Date:  2008-10-17       Impact factor: 31.745

9.  Altered thymic selection by overexpressing cellular FLICE inhibitory protein in T cells causes lupus-like syndrome in a BALB/c but not C57BL/6 strain.

Authors:  G Qiao; Z Li; A W Minto; J Shia; L Yang; L Bao; J Tschopp; J-X Gao; J Wang; R J Quigg; J Zhang
Journal:  Cell Death Differ       Date:  2009-10-09       Impact factor: 15.828

Review 10.  The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis.

Authors:  Keith D Brown; Estefania Claudio; Ulrich Siebenlist
Journal:  Arthritis Res Ther       Date:  2008-08-21       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.